Critical Care Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: CB1C8F25B478EN
Market Monitor Global

Abstracts

Critical care drugs are the drugs used in an emergency, which helps to treat major injuries and illness.

This report contains market size and forecasts of Critical Care Drug in Global, including the following market information:

Global Critical Care Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Critical Care Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Opioids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Critical Care Drug include Pfizer, Abbott, Cadila Pharmaceuticals, Haffkine Bio-Pharmaceutical, Neon Laboratories and Cambrex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Critical Care Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Critical Care Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Critical Care Drug Market Segment Percentages, by Type, 2021 (%)

• Opioids
• Sedatives
• Benzodiazepines
• Others

Global Critical Care Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Critical Care Drug Market Segment Percentages, by Application, 2021 (%)

• Operation Theatre
• Intensive Care Unit
• Others

Global Critical Care Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Critical Care Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Critical Care Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Critical Care Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Abbott
• Cadila Pharmaceuticals
• Haffkine Bio-Pharmaceutical
• Neon Laboratories
• Cambrex

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Critical Care Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Critical Care Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CRITICAL CARE DRUG OVERALL MARKET SIZE

2.1 Global Critical Care Drug Market Size: 2021 VS 2028
2.2 Global Critical Care Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Critical Care Drug Players in Global Market
3.2 Top Global Critical Care Drug Companies Ranked by Revenue
3.3 Global Critical Care Drug Revenue by Companies
3.4 Top 3 and Top 5 Critical Care Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Critical Care Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Critical Care Drug Players in Global Market
  3.6.1 List of Global Tier 1 Critical Care Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Critical Care Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Critical Care Drug Market Size Markets, 2021 & 2028
  4.1.2 Opioids
  4.1.3 Sedatives
  4.1.4 Benzodiazepines
  4.1.5 Others
4.2 By Type - Global Critical Care Drug Revenue & Forecasts
  4.2.1 By Type - Global Critical Care Drug Revenue, 2017-2022
  4.2.2 By Type - Global Critical Care Drug Revenue, 2023-2028
  4.2.3 By Type - Global Critical Care Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Critical Care Drug Market Size, 2021 & 2028
  5.1.2 Operation Theatre
  5.1.3 Intensive Care Unit
  5.1.4 Others
5.2 By Application - Global Critical Care Drug Revenue & Forecasts
  5.2.1 By Application - Global Critical Care Drug Revenue, 2017-2022
  5.2.2 By Application - Global Critical Care Drug Revenue, 2023-2028
  5.2.3 By Application - Global Critical Care Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Critical Care Drug Market Size, 2021 & 2028
6.2 By Region - Global Critical Care Drug Revenue & Forecasts
  6.2.1 By Region - Global Critical Care Drug Revenue, 2017-2022
  6.2.2 By Region - Global Critical Care Drug Revenue, 2023-2028
  6.2.3 By Region - Global Critical Care Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Critical Care Drug Revenue, 2017-2028
  6.3.2 US Critical Care Drug Market Size, 2017-2028
  6.3.3 Canada Critical Care Drug Market Size, 2017-2028
  6.3.4 Mexico Critical Care Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Critical Care Drug Revenue, 2017-2028
  6.4.2 Germany Critical Care Drug Market Size, 2017-2028
  6.4.3 France Critical Care Drug Market Size, 2017-2028
  6.4.4 U.K. Critical Care Drug Market Size, 2017-2028
  6.4.5 Italy Critical Care Drug Market Size, 2017-2028
  6.4.6 Russia Critical Care Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Critical Care Drug Market Size, 2017-2028
  6.4.8 Benelux Critical Care Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Critical Care Drug Revenue, 2017-2028
  6.5.2 China Critical Care Drug Market Size, 2017-2028
  6.5.3 Japan Critical Care Drug Market Size, 2017-2028
  6.5.4 South Korea Critical Care Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Critical Care Drug Market Size, 2017-2028
  6.5.6 India Critical Care Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Critical Care Drug Revenue, 2017-2028
  6.6.2 Brazil Critical Care Drug Market Size, 2017-2028
  6.6.3 Argentina Critical Care Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Critical Care Drug Revenue, 2017-2028
  6.7.2 Turkey Critical Care Drug Market Size, 2017-2028
  6.7.3 Israel Critical Care Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Critical Care Drug Market Size, 2017-2028
  6.7.5 UAE Critical Care Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Critical Care Drug Major Product Offerings
  7.1.4 Pfizer Critical Care Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Critical Care Drug Major Product Offerings
  7.2.4 Abbott Critical Care Drug Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Cadila Pharmaceuticals
  7.3.1 Cadila Pharmaceuticals Corporate Summary
  7.3.2 Cadila Pharmaceuticals Business Overview
  7.3.3 Cadila Pharmaceuticals Critical Care Drug Major Product Offerings
  7.3.4 Cadila Pharmaceuticals Critical Care Drug Revenue in Global Market (2017-2022)
  7.3.5 Cadila Pharmaceuticals Key News
7.4 Haffkine Bio-Pharmaceutical
  7.4.1 Haffkine Bio-Pharmaceutical Corporate Summary
  7.4.2 Haffkine Bio-Pharmaceutical Business Overview
  7.4.3 Haffkine Bio-Pharmaceutical Critical Care Drug Major Product Offerings
  7.4.4 Haffkine Bio-Pharmaceutical Critical Care Drug Revenue in Global Market (2017-2022)
  7.4.5 Haffkine Bio-Pharmaceutical Key News
7.5 Neon Laboratories
  7.5.1 Neon Laboratories Corporate Summary
  7.5.2 Neon Laboratories Business Overview
  7.5.3 Neon Laboratories Critical Care Drug Major Product Offerings
  7.5.4 Neon Laboratories Critical Care Drug Revenue in Global Market (2017-2022)
  7.5.5 Neon Laboratories Key News
7.6 Cambrex
  7.6.1 Cambrex Corporate Summary
  7.6.2 Cambrex Business Overview
  7.6.3 Cambrex Critical Care Drug Major Product Offerings
  7.6.4 Cambrex Critical Care Drug Revenue in Global Market (2017-2022)
  7.6.5 Cambrex Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Critical Care Drug Market Opportunities & Trends in Global Market
Table 2. Critical Care Drug Market Drivers in Global Market
Table 3. Critical Care Drug Market Restraints in Global Market
Table 4. Key Players of Critical Care Drug in Global Market
Table 5. Top Critical Care Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Critical Care Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Critical Care Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Critical Care Drug Product Type
Table 9. List of Global Tier 1 Critical Care Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Critical Care Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Critical Care Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Critical Care Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Critical Care Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Critical Care Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Critical Care Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Critical Care Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Critical Care Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Critical Care Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Critical Care Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Critical Care Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Critical Care Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Critical Care Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Critical Care Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Critical Care Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Critical Care Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Critical Care Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Critical Care Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Critical Care Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Critical Care Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Critical Care Drug Product Offerings
Table 32. Pfizer Critical Care Drug Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Critical Care Drug Product Offerings
Table 35. Abbott Critical Care Drug Revenue (US$, Mn), (2017-2022)
Table 36. Cadila Pharmaceuticals Corporate Summary
Table 37. Cadila Pharmaceuticals Critical Care Drug Product Offerings
Table 38. Cadila Pharmaceuticals Critical Care Drug Revenue (US$, Mn), (2017-2022)
Table 39. Haffkine Bio-Pharmaceutical Corporate Summary
Table 40. Haffkine Bio-Pharmaceutical Critical Care Drug Product Offerings
Table 41. Haffkine Bio-Pharmaceutical Critical Care Drug Revenue (US$, Mn), (2017-2022)
Table 42. Neon Laboratories Corporate Summary
Table 43. Neon Laboratories Critical Care Drug Product Offerings
Table 44. Neon Laboratories Critical Care Drug Revenue (US$, Mn), (2017-2022)
Table 45. Cambrex Corporate Summary
Table 46. Cambrex Critical Care Drug Product Offerings
Table 47. Cambrex Critical Care Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Critical Care Drug Segment by Type in 2021
Figure 2. Critical Care Drug Segment by Application in 2021
Figure 3. Global Critical Care Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Critical Care Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Critical Care Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Critical Care Drug Revenue in 2021
Figure 8. By Type - Global Critical Care Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Critical Care Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Critical Care Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Critical Care Drug Revenue Market Share, 2017-2028
Figure 12. US Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Critical Care Drug Revenue Market Share, 2017-2028
Figure 16. Germany Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Critical Care Drug Revenue Market Share, 2017-2028
Figure 24. China Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Critical Care Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Critical Care Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Critical Care Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Critical Care Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Critical Care Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cadila Pharmaceuticals Critical Care Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Haffkine Bio-Pharmaceutical Critical Care Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Neon Laboratories Critical Care Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cambrex Critical Care Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)